United States Pharmaceutical Logistics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 120 Pages I Mordor Intelligence
United States Pharmaceutical Logistics Market Analysis
The United States Pharmaceutical Logistics Market was valued at USD 75.96 billion in 2025 and estimated to grow from USD 78.53 billion in 2026 to reach USD 92.67 billion by 2031, at a CAGR of 3.38% during the forecast period (2026-2031).
The United States pharmaceutical logistics market size projection underscores how compliance deadlines and biologics demand are reshaping cost structures and service design. A tightening Drug Supply Chain Security Act (DSCSA) timetable, expiring in August 2025, forces serialization investments that only well-capitalized providers can execute, granting them premium pricing latitude. Surging GLP-1 weight-management therapies, the steady rise of cell and gene treatments, and direct-to-patient (DTP) fulfillment further enlarge the United States pharmaceutical logistics market, pressing operators to expand temperature-controlled capacity at speed. Manufacturers are simultaneously formulating ambient-stable versions of existing drugs to curb rising freight costs, tempering the relative growth of non-cold-chain flows yet creating new packaging and labeling work for value-added service (VAS) providers. Regional network redesign is underway, with the Midwest gaining share as a national hub while capacity additions in the South ease congestion on coastal corridors.
United States Pharmaceutical Logistics Market Trends and Insights
Expansion of Specialty Biologics Requiring Strict Temperature Control
Temperature-controlled transport costs three to five times more than ambient freight, and 80% of therapies shipped in developed markets now need 2-8 C custody, elevating cold-chain complexity. UPS moved early by paying USD 1.6 billion for Andlauer Healthcare Group in April 2025, adding 1.7 million ft of GDP-certified storage and extending its -80 C freezer network. Biologics also shorten order-to-delivery cycles, driving demand for high-frequency replenishment lanes rather than bulk shipments. Smaller carriers struggle to finance the continuous monitoring systems the FDA now audits for excursion logs, accelerating consolidation. As cold-chain nodes multiply in secondary markets, operators gain geographic flexibility but must coordinate inventory at added hand-off points, intensifying the need for AI-driven route visibility.
DSCSA Serialization Deadline Boosting Trace-and-Trace Investments
The FDA requires full unit-level traceability on prescription medicines by August 2025, splitting the United States pharmaceutical logistics market between serialization-ready providers and those facing restricted access. Implementation complexity is evident in TraceLink's B2N network, which processed 6 million EPCIS events in 90 days yet logged a 30% data-error rate that could trigger daily product quarantines. Up-front system costs, estimated at USD 0.06 per saleable unit, invite pooling solutions run by third-party logistics specialists. Providers that embed DSCSA compliance into VAS packages not only lock in retainer fees but also deepen buyer dependence on their digital ecosystems for recall management, shortage mitigation, and contract manufacturing oversight.
Fuel-Price Volatility Inflating Distribution Costs
WTI spot prices swung 23% in 2024-2025, leaving pharma carriers with unmatched fuel-surcharge formulas that lag cost spikes by weeks. Temperature-controlled trucks burn 12% more diesel to power reefers, amplifying exposure. While LNG and electric tractor pilots show promise, range limits and sparse charging networks curtail adoption on coast-to-coast lanes. Route-optimization software and multi-stop milk-run models reduce empty miles, but product-integrity rules still cap load consolidation.
Other drivers and restraints analyzed in the detailed report include:
Surge in GLP-1 Obesity/Diabetes Drug Volumes Stressing Cold-Chain CapacityGrowth of Direct-to-Patient Distribution ModelsGeneric-Drug Price Erosion Squeezing Logistics Margins
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Transportation still anchors revenue, yet the United States pharmaceutical logistics market shows a clear migration toward bundled solutions. In 2025, transportation delivered 70.45% of turnover, but value-added services are expected to outpace at a 4.75% CAGR (2026-2031) as clients seek serialization, relabeling, and kitting alongside freight. Road freight's share remains resilient due to final-mile and rural clinic deliveries, with sensors and dual-compartment trailers adding compliance. Air freight, while costly, preserves its niche for cell therapy and compassionate-use shipments that tolerate no delay. Ocean carriage gains as shippers divert stable formulation APIs to controlled-atmosphere reefers on Asia-to-US lanes, aligning with ESG goals and securing uplift during air-capacity crunches.
Rail remains marginal, hindered by limited GDP-certified hand-off nodes. Warehouse & storage demand tightens as DSCSA elevates traceability, turning depots into digital serialization hubs where 2D data-matrix codes are verified before release. This pushes automation projects-vision-system scanners and autonomous pallet movers-to squeeze latency out of compliance checks. The fastest growth occurs in VAS, including pallet reconfiguration, late-stage customization, and documentation for import-export variance.
The United States Pharmaceutical Logistics Market Report is Segmented by Service Type (Transportation, Warehousing & Storage, and Value-Added Services & Others), Mode of Operation (Cold-Chain Logistics and Non-Cold-Chain Logistics), Product Type (Prescription Drugs, Biologics & Biosimilars, Veterinary Medicine, and More), Region (Northeast, Midwest, South, and West). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
DHL Supply Chain & Global Forwarding FedEx UPS Cencora C.H. Robinson XPO Logistics Ryder System Penske Logistics Expeditors International SEKO Logistics LifeScience Logistics MD Logistics DSV Kuehne + Nagel Hub Group Nippon Express CEVA Logistics GXO Logistics KRC Logistics Langham Logistics Crown LSP Group
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Expansion of specialty biologics requiring strict temperature control
4.2.2 DSCSA serialization deadline boosting trace-and-trace investments
4.2.3 Surge in GLP-1 obesity/diabetes drug volumes stressing cold-chain capacity
4.2.4 Sustainability-driven modal shift from air to sea freight
4.2.5 Growth of direct-to-patient distribution models
4.2.6 AI-enabled "control-tower" routing and predictive spoilage analytics reducing lead times
4.3 Market Restraints
4.3.1 Fuel-price volatility inflating distribution costs
4.3.2 Generic-drug price erosion squeezing logistics margins
4.3.3 Shortage of ultra-low-temperature technicians & drivers
4.3.4 Cyber-attacks on IoT cold-chain infrastructure
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Service Type
5.1.1 Transportation
5.1.1.1 Road Freight
5.1.1.2 Air Freight
5.1.1.3 Sea Freight
5.1.1.4 Rail Freight
5.1.2 Warehousing & Storage
5.1.3 Value-added Services and Others
5.2 By Mode of Operation
5.2.1 Cold-Chain Logistics
5.2.2 Non-Cold-Chain Logistics
5.3 By Product Type
5.3.1 Prescription Drugs
5.3.2 OTC Drugs
5.3.3 Biologics & Biosimilars
5.3.4 Vaccines & Blood Products
5.3.5 Clinical Trail Materials
5.3.6 Cell & Gene Therapies
5.3.7 Medical Devices & Diagnostics
5.3.8 Veterinary Medicine
5.3.9 Others
5.4 By Region (United States)
5.4.1 Northeast
5.4.2 Midwest
5.4.3 South
5.4.4 West
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 DHL Supply Chain & Global Forwarding
6.4.2 FedEx
6.4.3 UPS
6.4.4 Cencora
6.4.5 C.H. Robinson
6.4.6 XPO Logistics
6.4.7 Ryder System
6.4.8 Penske Logistics
6.4.9 Expeditors International
6.4.10 SEKO Logistics
6.4.11 LifeScience Logistics
6.4.12 MD Logistics
6.4.13 DSV
6.4.14 Kuehne + Nagel
6.4.15 Hub Group
6.4.16 Nippon Express
6.4.17 CEVA Logistics
6.4.18 GXO Logistics
6.4.19 KRC Logistics
6.4.20 Langham Logistics
6.4.21 Crown LSP Group
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.